ITCI
DnB Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-87,569
| Closed | -$7.31M | – | 774 |
|
|
2024
Q4 | $7.31M | Sell |
87,569
-10,497
| -11% | -$877K | 0.03% | 320 |
|
|
2024
Q3 | $7.18M | Buy |
98,066
+17,911
| +22% | +$1.31M | 0.03% | 322 |
|
|
2024
Q2 | $5.48M | Buy |
80,155
+13,402
| +20% | +$917K | 0.03% | 341 |
|
|
2024
Q1 | $4.62M | Buy |
66,753
+56,453
| +548% | +$3.91M | 0.02% | 364 |
|
|
2023
Q4 | $738K | Sell |
10,300
-1,894
| -16% | -$136K | ﹤0.01% | 611 |
|
|
2023
Q3 | $635K | Sell |
12,194
-2,079
| -15% | -$108K | ﹤0.01% | 626 |
|
|
2023
Q2 | $904K | Buy |
14,273
+4,151
| +41% | +$263K | 0.01% | 614 |
|
|
2023
Q1 | $548K | Buy |
+10,122
| New | +$548K | ﹤0.01% | 627 |
|